27 completed, 13 terminated, 8 recruiting, 6 active not recruiting. 31 Not applicable, 18 Phase 2, 2 Early Phase 1, 2 Phase 1, 1 Phase 3.
Follow Centre Jean Perrin: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Functional Imaging of Digital Osteoarthritis and Rheumatoid Arthritis Using 99mTc-NTP 15-5 in Nuclear Medicine 99mTc-NTP 15-5 at a diagnostic activity of 15 MBq/kg - Digital Osteoarthritis or Rheumatoid Arthritis | Phase 2 | Not yet recruiting | Centre Jean Perrin | 80 | 2026-10-01 | 2026-10-20 |
| Identification of Genetic, Phenotypic, Clinical, Biological and Histological Factors Differentiating Patients With Ovarian Cancer Who Are Refractory to Platinum-based Therapy From Patients Defined as Long-term Responders to Platinum-based Therapy molecular analysis - Ovarian Cancer | Not applicable | Recruiting | Centre Jean Perrin | 55 | 2026-01-22 | 2026-02-20 |
| cDNA and Residual Disease After Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinomas blood sampling - Locally Advanced Head and Neck Carcinoma | Not applicable | Recruiting | Centre Jean Perrin | 59 | 2025-10-13 | 2026-09-11 |
| Augmented Reality Feasibility for Non-invasive Preoperative Tracking in Breast Cancer Surgery Additional MRI with gadolinium injection and 3D camera imaging - Subclinical Breast Cancer Lesion | Not applicable | Recruiting | Centre Jean Perrin | 20 | 2024-11-14 | 2025-12-31 |
| Identification of New Candidate Genes for Hereditary Predisposition to Uveal Melanoma Constitutional exome analysis - Uveal Melanoma | Not applicable | Recruiting | Centre Jean Perrin | 50 | 2024-10-29 | 2026-03-19 |
| Intrinsic Validity of Molecular Marker(s) Detection on Tissular Tumoral DNA to Predict the Efficacy of 177Lutetium-PSMA-617 (Lu-PSMA) Treatment for Castration-resistant Metastatic Prostate Cancer Blood samples - Castration-resistant Metastatic Prostate Cancer, Treated by 177Lutetium-PSMA-617 (Lu-PSMA) | Not applicable | Recruiting | Centre Jean Perrin | 120 | 2024-10-08 | 2025-12-31 |
| Impact of Implementing the Modified A-DIVA Scale on Successful Access to a Venous Line on the First Attempt Training in the A-DIVA scale and its failure prediction score - Chronic Disease | Not applicable | Recruiting | Centre Jean Perrin | 200 | 2024-02-27 | 2025-04-04 |
| Prediction of Residual Disease by Circulating DNA Detection After Potentiated Radiotherapy for Locally Advanced Head and Neck Cancer Blood sample - Locally Advanced Head and Neck Carcinoma | Not applicable | Recruiting | Centre Jean Perrin | 63 | 2024-01-17 | 2026-09-11 |
| Support and Post-therapeutic Rehabilitation for Women in Complete Remission of Breast Cancer in a Thermal Environment Non-Metastatic Breast Carcinoma, Remission | Active not recruiting | Centre Jean Perrin | 400 | 2022-06-27 | 2025-08-26 | |
| AGuIX Nanoparticles With Radiotherapy Plus Concomitant Temozolomide in the Treatment of Newly Diagnosed Glioblastoma Polysiloxane Gd-Chelates based nanoparticles (AGuIX), radiotherapy, Temozolomide - Glioblastoma | Phase 1 / Phase 2 | Active not recruiting | Centre Jean Perrin | 66 | 2022-03-07 | 2026-10-22 |
| hPG80 (Circulating Progastrin) as a Blood Biomarker for High-grade Glial Tumors Blood sample - Glial Cell Tumors | Completed | Centre Jean Perrin | 30 | 2022-02-14 | 2025-09-22 | |
| Xenografts Development From Surgical Tumor Samples of Patients With Triple Negative or Luminal B Breast Cancer blood samples collection - Breast Cancer Female | Not applicable | Recruiting | Centre Jean Perrin | 85 | 2021-11-19 | 2026-03-19 |
| Interest of Broadband Spectroscopy Analysis by Infrared Laser on Liquid Biopsies in Breast Cancer Screening liquid biopsy - Breast Cancer Female, BRCA1 Mutation | Not applicable | Active not recruiting | Centre Jean Perrin | 1100 | 2021-05-31 | 2025-09-10 |
| Breast Localization: RFID Tags vs Wire Localization RFID tags, Wire localization - Breast Neoplasm Female | Completed | Centre Jean Perrin | 80 | 2021-05-15 | 2023-06-18 | |
| Preoperative Stereotactic Radiosurgery for Brain Metastases Preoperative SRS - Brain Metastases | Phase 2 | Completed | Centre Jean Perrin | 70 | 2021-02-04 | 2025-12-04 |
| Evaluation of a Plasma Protein Profile as a Predictive Biomarker for Metastatic Relapse in Triple Negative Breast Cancer Patients Triple Negative Breast Cancer | Active not recruiting | Centre Jean Perrin | 90 | 2020-11-27 | 2025-12-04 | |
| Assessment of 99mTc-NTP 15-5 Uptake on Cartilage, a New Proteoglycan Tracer 99mTc-NTP 15-5 at a diagnostic activity of 5 MBq/kg, 99mTc-NTP 15-5 at a diagnostic activity of 10 MBq/kg, 99mTc-NTP 15-5 at a diagnostic activity of 15 MBq/kg - Osteoarthritis, Knee, Breast Cancer | Early Phase 1 | Completed | Centre Jean Perrin | 6 | 2020-11-12 | 2024-10-01 |
| Correlation Between TILs and Blood Cell Counts in Triple Negative Breast Cancer Patients Blood sample - Triple Negative Breast Cancer | Active not recruiting | Centre Jean Perrin | 90 | 2019-12-04 | 2026-03-20 | |
| Targeted Radionuclide Therapy for Metastatic Melanoma [131I] ICF01012 [131I]ICF01012 (therapeutic dose level 1), [131I]ICF01012 (therapeutic dose level 2), [131I]ICF01012 (therapeutic dose level 3) - Melanoma | Early Phase 1 | Completed | Centre Jean Perrin | 10 | 2019-10-18 | 2025-02-13 |
| Loreline Study: Characterization of Long Responders Under Eribuline Patients in long response during Halaven® treatment - Breast Cancer Patients, Therapy Related Tumor | Completed | Centre Jean Perrin | 97 | 2019-08-23 | 2021-04-05 |
Showing 20 of 60. Sign in to see all of them.
Breast Neoplasms (20) · Neoplasms (3) · Ovarian Neoplasms (3) · Triple Negative Breast Neoplasms (3) · Chronic Disease (2) · Glioblastoma (2) · Glioma (2) · Head and Neck Neoplasms (2) · Hypersensitivity (2) · Pain (2) · Anxiety Disorders (1) · Arthritis, Rheumatoid (1) · Body Weight (1) · Brain Neoplasms (1) · Breast Neoplasms, Male (1)
Docetaxel (6) · Blood Specimen Collection (5) · Cyclophosphamide (4) · Cisplatin (2) · Curcumin (2) · Epirubicin (2) · Fluorouracil (2) · Radiotherapy (2) · Temozolomide (2) · AGuIX (1) · Cetuximab (1) · Cosmetics (1) · Drug Therapy (1) · Enoxaparin (1) · Enteral Nutrition (1)
France (58)
Philippe Chollet, MD (2) · Philippe Chollet, MD, PhD (2) · Annick Bernalier-Donadille, Dr (1) · Christophe Pomel, MD, PhD (1) · Corinne Bouteloup, Doctor (1) · Edith Filaire, Pr (1)
PMID 11136411, PMID 24827135, PMID 25575640, PMID 25637380, PMID 26649807, PMID 27769293, PMID 29133320, PMID 30417829, PMID 30858899, PMID 31020630, PMID 32450847, PMID 32758188, PMID 33327268, PMID 34249349, PMID 34249690, PMID 34320940, PMID 34554698, PMID 34966667, PMID 35428211, PMID 36314021, PMID 36712425, PMID 37060055, PMID 37468859, PMID 37932443, PMID 38919520, PMID 39844175, PMID 39881247, PMID 39926282, PMID 41003883, PMID 41421991, PMID 41462069, PMID 41632122, PMID 41812302, PMID 42857443
2014 (1), 2016 (1), 2017 (1), 2025 (1)